Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605427 | Sublingual semaglutide-BPC 157 combination for weight loss | 🖼🧊📄§ | 2026-04-21 | 2043-05-15 | 0 | 31 |
| 12606602 | Recombinant CCN domain proteins and fusion proteins | 🖼🧊📄§ | 2026-04-21 | 2040-03-20 | 0 | 31 |
| 12606795 | Akkermansia muciniphila and product and application thereof | 🖼🧊📄§ | 2026-04-21 | 2044-03-27 | 0 | 31 |
| 12606843 | CAS9 fusion proteins, RNA-guided gene editing, gene regulation compositions, and methods comprising the same | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12605482 | Systems and methods of preparing and delivering oocyst solutions | 🖼🧊📄§ | 2026-04-21 | 2039-07-10 | 0 | 31 |
| 12605447 | Stable formulations for radionuclide complexes | 🖼🧊📄§ | 2026-04-21 | 2045-01-17 | 0 | 31 |
| 12604930 | Non-burning type flavor inhaler and control method | 🖼🧊📄§ | 2026-04-21 | 2040-12-03 | 0 | 31 |
| 12605466 | Enhanced human opsin promoter for rod specific expression | 🖼🧊📄§ | 2026-04-21 | 2040-03-04 | 0 | 31 |
| 12605462 | Porous silicon nanoparticle-based drug delivery system inducing reactive oxygen species and self-activation thereof, and method for preparing same | 🖼🧊📄§ | 2026-04-21 | 2042-05-09 | 0 | 31 |
| 12605305 | Application of citrate metal salt in endodontic treatment, and formulation obtained by preparation | 🖼🧊📄§ | 2026-04-21 | 2041-07-19 | 0 | 31 |
| 12605459 | Protein-drug conjugates comprising camptothecin analogs and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-12 | 0 | 31 |
| 12605453 | CP2C-targeting peptide-based anticancer agent | 🖼🧊📄§ | 2026-04-21 | 2040-04-01 | 0 | 31 |
| 12605469 | Tumor specific antibody conjugates and uses therefor | 🖼🧊📄§ | 2026-04-21 | 2042-08-03 | 0 | 31 |
| 12606546 | Small molecule inhibitors of calcium channel activity and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2042-12-20 | 0 | 31 |
| 12605307 | Dental composite material | 🖼🧊📄§ | 2026-04-21 | 2040-10-29 | 0 | 31 |
| 12606517 | Ibuprofen ester derivative and emulsion preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-06-29 | 0 | 31 |
| 12605454 | Modified virus-like particles of CMV | 🖼🧊📄§ | 2026-04-21 | 2042-04-06 | 0 | 31 |
| 12605312 | Preparation method and application of single emulsifier and double emulsion based on DNA triangular origami technology | 🖼🧊📄§ | 2026-04-21 | 2042-05-24 | 0 | 31 |
| 12605351 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | 🖼🧊📄§ | 2026-04-21 | 2040-02-06 | 0 | 31 |
| 12604890 | Oxygen reduction disposable kits, devices and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2043-04-07 | 0 | 31 |
| 12605440 | Microneedle containing influenza vaccine and influenza vaccine patch containing the same | 🖼🧊📄§ | 2026-04-21 | 2042-12-22 | 0 | 31 |
| 12605342 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-04-21 | 2044-04-10 | 0 | 31 |
| 12605517 | Compositions, devices, and methods for intranasal delivery of dry powder epinephrine | 🖼🧊📄§ | 2026-04-21 | 2045-06-18 | 0 | 31 |
| 12605384 | Uses | 🖼🧊📄§ | 2026-04-21 | 2043-06-29 | 0 | 31 |
| 12605397 | Deoxy-cytidine or uridine derivatives for use in cancer therapies | 🖼🧊📄§ | 2026-04-21 | 2044-03-12 | 0 | 31 |
| 12605374 | Methods for drug screening and compositions useful for the inhibition of cell proliferation and/or cell survival | 🖼🧊📄§ | 2026-04-21 | 2040-11-30 | 0 | 31 |
| 12605570 | Apparatus and method for ultrasound spinal cord stimulation | 🖼🧊📄§ | 2026-04-21 | 2044-11-26 | 0 | 31 |
| 12607638 | Methods of treating inflammatory and autoimmune diseases with natalizumab | 🖼🧊📄§ | 2026-04-21 | 2042-05-16 | 0 | 31 |
| 12605347 | Solid dispersion of ursolic acid and potassium salt | 🖼🧊📄§ | 2026-04-21 | 2040-10-30 | 0 | 31 |
| 12606608 | Modified NK-92 cells, and therapeutic and diagnostic uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-09 | 0 | 31 |
| 12605539 | Methods and systems for delivering drugs through skin of a body | 🖼🧊📄§ | 2026-04-21 | 2040-06-24 | 0 | 31 |
| 12606637 | Heparanase-neutralizing A54 monoclonal antibody | 🖼🧊📄§ | 2026-04-21 | 2041-07-06 | 0 | 31 |
| 12605444 | Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same | 🖼🧊📄§ | 2026-04-21 | 2041-01-08 | 0 | 31 |
| 12605438 | SARS-CoV-2 vaccines and antibodies | 🖼🧊📄§ | 2026-04-21 | 2043-03-02 | 0 | 31 |
| 12605389 | PI3K-δ inhibitor for use in treatment regimens | 🖼🧊📄§ | 2026-04-21 | 2042-03-29 | 0 | 31 |
| 12605426 | Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof | 🖼🧊📄§ | 2026-04-21 | 2041-02-15 | 0 | 31 |
| 12605317 | Water-in-oil makeup cosmetic composition having water resistance and cleansing properties | 🖼🧊📄§ | 2026-04-21 | 2042-01-19 | 0 | 31 |
| 12605373 | Methods and compositions of inhibiting DCN1-UBC12 interaction | 🖼🧊📄§ | 2026-04-21 | 2044-03-05 | 0 | 31 |
| 12605400 | Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment | 🖼🧊📄§ | 2026-04-21 | 2040-04-29 | 0 | 31 |
| 12605330 | Screening method for offensive odor-suppressing material | 🖼🧊📄§ | 2026-04-21 | 2040-10-30 | 0 | 31 |
| 12605418 | Chebulinic acid and its enriched fraction from the fruits of Terminalia chebula for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-09-13 | 0 | 31 |
| 12605325 | Hair styling compositions for improving the elongation of hair curls | 🖼🧊📄§ | 2026-04-21 | 2040-06-30 | 0 | 31 |
| 12605350 | Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component | 🖼🧊📄§ | 2026-04-21 | 2041-06-30 | 0 | 31 |
| 12605358 | Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-02-16 | 0 | 31 |
| 12605315 | External skin preparation | 🖼🧊📄§ | 2026-04-21 | 2039-12-27 | 0 | 31 |
| 12605337 | Nanoparticle drug targeting JFK and use thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605357 | Bioactive supplement | 🖼🧊📄§ | 2026-04-21 | 2041-02-04 | 0 | 31 |
| 12605345 | Transdermal drug delivery system | 🖼🧊📄§ | 2026-04-21 | 2043-12-01 | 0 | 31 |
| 12606829 | Compositions for herpesvirus transcriptional feedback circuit disruption and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2039-06-12 | 0 | 31 |
| 12606533 | 3-phenylpropylamine derivative | 🖼🧊📄§ | 2026-04-21 | 2045-04-11 | 0 | 31 |